Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies

Featuring an interview with Dr Jennifer Crombie, including the following topics:

• Overview of similarities and differences among CD20 x CD3 targeted bispecific antibodies for the treatment of lymphomas (0:00)
• Optimal integration of CD20 x CD3 bispecific antibodies into treatment algorithms for lymphomas (9:40)
• Case: A man in his late 60s with relapsed follicular lymphoma (FL) who received mosunetuzumab (23:52)
• Case: A man in his late 80s with transformed, double-hit diffuse large B-cell lymphoma (DLBCL) who received epcoritamab (28:46)
• Case: A woman in her early 70s with recurrent FL who received odronextamab on the ELM-1 trial (34:06)
• Case: A man in his early 80s with multiregimen-relapsed DLBCL who receives glofitamab (43:19)

CME information and select publications